Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 246 Records) |
| Query Trace: Polycythemia and JAK2[original query] |
|---|
| Novel JAK2 Exon 14 Mutations L611S or N622Y in cis with JAK2V617F Are Associated with Distinct Clinical Phenotype of Polycythemia Vera and Concurrent Eosinophilia. Acta haematologica 2022 11 146 (1): 76-81. Patel Ameet, Juskevicius Ridas, Mohan Sanj |
| JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. Journal of cancer research and clinical oncology 2022 Oct . Kandu?a Zuzanna, Janowski Micha?, Wi?ckowska Barbara, Paczkowska Edyta, Lewandowski Krzyszt |
| The molecular profile in patients with polycythemia vera and essential thrombocythemia is dynamic and correlates with disease's phenotype. Frontiers in oncology 2023 9 13 1224590. Patryk Sobieralski, Bartosz Was?g, Aleksandra Leszczy?ska, Monika ?uk, Maria Bieniaszews |
| The Clinical Impact of JAK2V617F allele burden in Philadelphia-negative Myeloproliferative Neoplasms. Turkish journal of haematology : official journal of Turkish Society of Haematology 2023 8 . ?pek Yönal-Hindilerden, Ezgi ?ahin, Fehmi Hindilerden, Aynur Da?lar-Aday, Meliha Nalça |
| Clinical Characteristics and Outcomes of Patients with Primary and Secondary Myelofibrosis According to the Genomic Classification Using Targeted Next-Generation Sequencing. Cancers 2023 8 15 (15): . Marta Garrote, Mónica López-Guerra, Eduardo Arellano-Rodrigo, María Rozman, Sara Carbonell, Francesca Guijarro, Marta Santaliestra, Ana Triguero, Dolors Colomer, Francisco Cervantes, Alberto Álvarez-Larr |
| Expression properties, structural features and functional analysis of CALR E381A in MPN patients. American journal of translational research 2023 8 15 (7): 4718-4726. Kaihong Xu, Qunfang Ge, Yanli Zhang, Guifang Ouyang, Xiao Y |
| Myeloid/Lymphoid Neoplasm with FGFR1 Rearrangement Presenting with Polycythemia Vera and T-cell Acute Lymphoblastic Leukemia. Cancer genetics 2023 7 276-277 43-47. Lisa M Marinelli, Joshua T Romain, William Ehman, Veronica Ortega, Gopalrao Velagaleti, Thomas F Gibbons, Ashley Nazario-Toole, Allen R Holm |
| Whole Exome Sequencing Reveals Novel Variants in Unexplained Erythrocytosis. Omics : a journal of integrative biology 2023 7 . Harshit Khurana, Babylakshmi Muthusamy, Uday Yanamandra, Kishore Garapati, Harikrishnan Premdeep, Shankar Subramanian, Akhilesh Pand |
| A Screening Approach for Inherited Erythrocytosis due to the VHL:c.598C?>?T Mutation (Chuvash Polycythemia). Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2023 6 1-5. Nisha Duggal, Namrata Singh, Suchet Sachdev, Avinash Kumar Singh, Jasbir Kaur Hira, Sanjeev Chhabra, Deepak Bansal, Pankaj Malhotra, Neelam Varma, Reena Das, Prashant Shar |
| Allelic burden of Janus kinase 2 in a 6-month course of therapy for myeloproliferative neoplasms. Molecular biology reports 2023 5 . It?r ?irino?lu Demiriz, Mehmet Hanifi Kazanci, Esra Menfaatli, Davoud Jafari-Gharabaghlou, Nosratollah Zargha |
| Increase in Frequency of Myeloid-Derived Suppressor Cells in the Bone Marrow of Myeloproliferative Neoplasm: Potential Implications in Myelofibrosis. Advances in experimental medicine and biology 2023 4 1408 273-290. Sun?ica Kapor, Sanja Mom?ilovi?, Slobodan Kapor, Slavko Mojsilovi?, Milica Radojkovi?, Milica Apostolovi?, Branka Filipovi?, Mirjana Goti?, Vladan ?oki?, Juan F Santiban |
| Iron homeostasis governs erythroid phenotype in Polycythemia Vera. Blood 2023 3 . Bennett Cavan, Jackson Victoria E, Pettikiriarachchi Anne, Hayman Thomas, Schaeper Ute, Moir-Meyer Gemma L, Fielding Katherine Louise, Ataide Ricardo, Clucas Danielle, Baldi Andrew James, Garnham Alexandra L, Li-Wai-Suen Connie Sn, Loughran Stephen John, Baxter E Joanna, Green Anthony R, Alexander Warren S, Bahlo Melanie, Burbury Kate, Ng Ashley P, Pasricha Sant-Ra |
| Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL. Technology in cancer research & treatment 2023 2 22 15330338231154092. Wang Yan, Ran Fei, Lin Jin, Zhang Jing, Ma D |
| The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience. Cellular and molecular biology (Noisy-le-Grand, France) 2023 2 68 (8): 202-209. Basim Najm Maysam, Jalal Sana Dlawar, Getta Hisham Ar |
| JAK2, CALR, and MPL Mutation Profiles in Colombian patients with BCR-ABL Negative Myeloproliferative Neoplasms. Colombia medica (Cali, Colombia) 2023 12 54 (3): e2035353. Ana Isabel Giraldo-Rincón, Sara Naranjo Molina, Natalia Gomez-Lopera, Daniel Aguirre Acevedo, Andrea Ucroz Benavidez, Kenny Gálvez Cárdenas, Francisco Cuellar Ambrosí, Jose Domingo Torres, Sigifredo Ospina, Katherine Palacio, Lina Gaviria Jaramillo, Carlos Mario Muñeton, Gonzalo Vasquez Palac |
| JAK2V617F Mutation and Associated Chromosomal Alterations in Primary and Secondary Myelofibrosis and Post-HCT Outcomes. Blood advances 2023 11 . Maryam Rafati, Derek Brown, Weiyin Zhou, Kristine M Jones, Wen Luo, Andrew St Martin, Youjin Wang, Meilun He, Stephen R Spellman, Tao Wang, H Joachim Deeg, Vikas Gupta, Stephanie J Lee, Yung-Tsi Bolon, Stephen J Chanock, Mitchell J Machiela, Wael Saber, Shahinaz M Gadal |
| Detection of the JAK2 V617F Mutation in Urinary Cell-free DNA in Patients with Myeloproliferative Neoplasms. Internal medicine (Tokyo, Japan) 2023 11 . Hiroki Hosoi, Yoshikazu Hori, Katsuhiro Fukutsuka, Mitsuo Osuga, Yasuhiro Koh, Toshiki Mushino, Nobuyoshi Hanaoka, Nobuyuki Yamamoto, Hitoshi Ohno, Takashi Sono |
| Molecular landscape of the JAK2 gene in chronic myeloproliferative neoplasm patients from the state of Amazonas, Brazil. Biomedical reports 2023 11 19 (6): 98. Dania G Torres, Emanuela V Barbosa Alves, Miliane Araújo de Sousa, Wanessa H Laranjeira, Jhemerson Paes, Erycka Alves, Deborah Canté, Allyson G Costa, Adriana Malheiro, Rosângela Abreu, Leny Nascimento, Nelson A Fraiji, George A V Silva, Lucivana P de Souza Mourão, Andréa M Tarra |
| Arterial and Venous Thromboembolic Complications in 832 Patients with BCR-ABL-Negative Myeloproliferative Neoplasms. Hamostaseologie 2023 10 . Kai Wille, Eva Deventer, Parvis Sadjadian, Tatjana Becker, Vera Kolatzki, Karlo Hünerbein, Raphael Meixner, Marina Jiménez-Muñoz, Christiane Fuchs, Martin Griesshamm |
| Predictive significance of high neutrophil ratio for thrombosis in myeloproliferative neoplasms: JSH-MPN-R18 subanalysis. Annals of hematology 2024 7 . Keiki Nagaharu, Eiko Ohya, Yoko Edahiro, Yoshinori Hashimoto, Tomoki Ito, Akihiko Gotoh, Mika Nakamae, Fumihiko Kimura, Michiaki Koike, Keita Kirito, Hideho Wada, Kensuke Usuki, Takayuki Tanaka, Takehiko Mori, Satoshi Wakita, Toshiki I Saito, Akiko M Saito, Kazuya Shimoda, Toshiro Kurokawa, Akihiro Tomita, Hitoshi Kiyoi, Koichi Akashi, Itaru Matsumura, Katsuto Takenaka, Norio Komatsu, Kohshi Ohishi, Isao Tawara, Yuka Sugimo |
| [Analysis of risk factors for venous thromboembolism in patients with polycythemia vera and establishment of a prediction model]. Zhonghua yi xue za zhi 2024 7 104 (25): 2336-2341. J Y Ma, Y H Zhang, G S Teng, C X Du, H Q Zhang, Y Wang, Y Q Li, Y F Duan, Y Zhou, Z H Shao, J B |
| Prevalence and clinicopathological features of driver gene mutations profile in BCR: ABL1 negative classical myeloproliferative neoplasm-A single-center study from North India. Indian journal of pathology & microbiology 2024 5 . Khaliqur Rahman, Seema Biswas, Akhilesh Sharma, Kusum Gupta, Dinesh Chandra, Manish K Singh, Ruchi Gupta, Ashish Mishra, Sanjeev Kumar, Anshul Gupta, Faheema Hasan, Soniya Nityanand, Rajesh Kahsy |
| Two Novel Genetic Variants Involved in the Oxygen Sensing Pathway in JAK2-unmutated Erythrocytosis. Biochemical genetics 2024 4 . Qiang Ma, Ronghua Hu, Wuhan Hui, Hong Zhao, Dongmei Zou, Yan Liu, Wanling S |
| Exploring hematological alterations and genetics linked to SNV rs10974944 in myeloproliferative neoplasms among Amazon patients. Scientific reports 2024 4 14 (1): 9389. Jhemerson F Paes, Dania G Torres, Deborah C Aquino, Emanuela V B Alves, Erycka A Mesquita, Miliane A Sousa, Nelson Abrahim Fraiji, Leny N M Passos, Rosângela S Abreu, George A V Silva, Andréa M Tarragô, Lucivana P de Souza Mour |
| Association of JAK2V617F allele burden and clinical correlates in polycythemia vera: a systematic review and meta-analysis. Annals of hematology 2024 4 . Chih-Cheng Chen, Justin L Chen, Alex Jia-Hong Lin, Lennex Hsueh-Lin Yu, Hsin-An H |
| The Association Between Janus Kinase 2 and Factor V Leiden Mutations and Thrombotic Complications in Patients With Myeloproliferative Disorders: A Study From Saudi Arabia. Cureus 2024 12 16 (11): e74401. Wafaa S Sayed, Aws Al-Bayati, Lina G Elzubair, Sherif Mohamed, Mueed Alhart |
| Molecular Profile of BCR-ABL1 Negative Myeloproliferative Neoplasm in a Moroccan Population. Asian Pacific journal of cancer prevention : APJCP 2024 11 25 (11): 4013-4025. Somda Georgina Charlène Soro, Ghita Amalou, Sara Benchikh, Adil El Hamouchi, Hicham Charoute, Mourad Oukheda, Benani Bennani Abdelouaheb, Rachid Saile, Halima Lebrazi, Sanaa Nassereddi |
| Features and allele frequency of JAK2 Exon 12-mutated polycythemia vera in comparison with JAK2V617F-mutated disease. Archives of medical research 2024 10 56 (2): 103109. Chin-Hsuan Chuang, Ming-Chung Kuo, Jin-Hou Wu, Tung-Liang Lin, Po-Nan Wang, Yueh-Shih Chang, Tung-Hui Lin, Ting-Yu Huang, Yu-Shin Hung, Hsiao-Wen Kao, Che-Wei Ou, Hung Chang, Lee-Yung Sh |
| Genomic classification and outcomes of young patients with polycythemia vera and essential thrombocythemia according to the presence of splanchnic vein thrombosis and its chronology. Annals of hematology 2024 1 . Marta Garrote, Mónica López-Guerra, Juan Carlos García-Pagán, Eduardo Arellano-Rodrigo, Francisca Ferrer-Marín, Juan Carlos Hernández-Boluda, Beatriz Bellosillo, Meritxell Nomdedeu, Virginia Hernández-Gea, Ana Triguero, Francesca Guijarro, José Álamo, Anna Baiges, Fanny Turon, Dolors Colomer, Francisco Cervantes, Alberto Alvarez-Larr |
| Idiopathic erythrocytosis: a germline disease? Clinical and experimental medicine 2024 1 24 (1): 11. E M Elli, M Mauri, D D'Aliberti, I Crespiatico, D Fontana, S Redaelli, S Pelucchi, S Spinelli, B Manghisi, F Cavalca, A Aroldi, A Ripamonti, S Ferrari, S Palamini, F Mottadelli, L Massimino, D Ramazzotti, G Cazzaniga, A Piperno, C Gambacorti-Passerini, R Piaz |
- Page last reviewed:Feb 1, 2024
- Content source: